Sophie R Abber, Mina Velimirović, Anika N Sigel, Alan Duffy, Jamie Manwaring, Renee Rienecke, Daniel Le Grange, Dan V Blalock, Philip S Mehler, Megan Riddle, Thomas E Joiner
{"title":"Heterogeneous Presentations at Admission But Similar Treatment Response Across Latent Profiles of ARFID Prototypes in Children and Adolescents.","authors":"Sophie R Abber, Mina Velimirović, Anika N Sigel, Alan Duffy, Jamie Manwaring, Renee Rienecke, Daniel Le Grange, Dan V Blalock, Philip S Mehler, Megan Riddle, Thomas E Joiner","doi":"10.1002/erv.70024","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Avoidant/restrictive food intake disorder (ARFID) is defined by any combination of three prototypic motivations for dietary restriction (sensory-based avoidance, lack of interest, fear of aversive consequences), resulting in heterogeneous presentations. Some work suggests overlap of prototypes, but little is known about how prototypes cluster together. Further, little research exists on how prototype influences outcome.</p><p><strong>Methods: </strong>We applied latent profile analysis (LPA) to 159 treatment-seeking children and adolescents (ages 9-18, 63% female, 78% White) with ARFID using items assessing ARFID prototype on the Eating Disorders in Youth-Questionnaire (EDY-Q). Resulting profiles were compared on clinical presentation and change in ARFID, anxiety, and depressive symptoms following evidence-based higher-level-of-care treatment.</p><p><strong>Results: </strong>ARFID prototypes present heterogeneously. A 4-profile solution emerged from the LPA: ARFID-1 (with fear of aversive consequences; n = 26); ARFID-2 (with sensory-based avoidance and lack of interest; n = 43); ARFID-3 (with all three prototypes; n = 44); and Non-Endorsers (n = 53). While profiles differed on ARFID, anxiety, and depressive symptoms at admission, change in symptoms was similar across profiles.</p><p><strong>Conclusions: </strong>ARFID prototypes frequently overlap. Despite heterogeneity of ARFID prototypes, treatment outcome was similar across latent profiles, supporting continued categorisation of all these motivations for restrictive eating as ARFID. Future work is needed to further validate these profiles.</p>","PeriodicalId":48117,"journal":{"name":"European Eating Disorders Review","volume":" ","pages":""},"PeriodicalIF":3.4000,"publicationDate":"2025-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Eating Disorders Review","FirstCategoryId":"102","ListUrlMain":"https://doi.org/10.1002/erv.70024","RegionNum":2,"RegionCategory":"心理学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Avoidant/restrictive food intake disorder (ARFID) is defined by any combination of three prototypic motivations for dietary restriction (sensory-based avoidance, lack of interest, fear of aversive consequences), resulting in heterogeneous presentations. Some work suggests overlap of prototypes, but little is known about how prototypes cluster together. Further, little research exists on how prototype influences outcome.
Methods: We applied latent profile analysis (LPA) to 159 treatment-seeking children and adolescents (ages 9-18, 63% female, 78% White) with ARFID using items assessing ARFID prototype on the Eating Disorders in Youth-Questionnaire (EDY-Q). Resulting profiles were compared on clinical presentation and change in ARFID, anxiety, and depressive symptoms following evidence-based higher-level-of-care treatment.
Results: ARFID prototypes present heterogeneously. A 4-profile solution emerged from the LPA: ARFID-1 (with fear of aversive consequences; n = 26); ARFID-2 (with sensory-based avoidance and lack of interest; n = 43); ARFID-3 (with all three prototypes; n = 44); and Non-Endorsers (n = 53). While profiles differed on ARFID, anxiety, and depressive symptoms at admission, change in symptoms was similar across profiles.
Conclusions: ARFID prototypes frequently overlap. Despite heterogeneity of ARFID prototypes, treatment outcome was similar across latent profiles, supporting continued categorisation of all these motivations for restrictive eating as ARFID. Future work is needed to further validate these profiles.
期刊介绍:
European Eating Disorders Review publishes authoritative and accessible articles, from all over the world, which review or report original research that has implications for the treatment and care of people with eating disorders, and articles which report innovations and experience in the clinical management of eating disorders. The journal focuses on implications for best practice in diagnosis and treatment. The journal also provides a forum for discussion of the causes and prevention of eating disorders, and related health policy. The aims of the journal are to offer a channel of communication between researchers, practitioners, administrators and policymakers who need to report and understand developments in the field of eating disorders.